Acupuncture for Chemotherapy-induced Peripheral Neuropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03582423

Recruitment Status : Completed

First Posted : July 11, 2018

Last Update Posted : October 9, 2020

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Princess Margaret Hospital, Hong Kong

Information provided by (Responsible Party):

Zhong Lidan, Hong Kong Baptist University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	August 31, 2020
Actual Study Completion Date :	September 30, 2020

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Chan K, Lui L, Lam Y, Yu K, Lau K, Lai M, Lau W, Tai L, Mak C, Bian Z, Zhong LL. Efficacy and safety of electroacupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: a single-blinded, randomized, sham-controlled trial. Acupunct Med. 2022 Nov 3:9645284221125421. doi: 10.1177/09645284221125421. Online ahead of print.

Chan K, Lui L, Yu K, Lau K, Lai M, Lau W, Ng B, Zhong LLD, Bian ZX. The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial. Trials. 2020 Jan 9;21(1):58. doi: 10.1186/s13063-019-3972-5.

To Top